Phenotypic and functional analyses of dendritic cells in patients with lymphoproliferative disease of granular lymphocytes (LDGL)
- PMID: 16091452
- DOI: 10.1182/blood-2005-05-1972
Phenotypic and functional analyses of dendritic cells in patients with lymphoproliferative disease of granular lymphocytes (LDGL)
Abstract
We investigated whether dendritic cells (DCs) play a role in favoring granular lymphocyte (GL) proliferation in patients with lymphoproliferative disease of granular lymphocytes (LDGL). The presence of in vivo circulating DCs was studied in 11 patients (5 CD3+ and 6 CD3- LDGL). Autologous immature (iDCs) and mature (mDCs) DCs generated in vitro were studied for stimulatory activity on cell proliferation of CD3+ and CD3- GLs. The topographic organization of GLs and DCs was also studied in bone marrow (BM) biopsies. Peripheral blood (PB) CD3- GLs from patients showed significant proliferative activity in the presence of iDCs and mDCs. Conversely, monoclonal CD3+ GLs were unresponsive to autologous and allogeneic PB DCs. Analysis of BM biopsies demonstrated a topographic distribution of DCs and GLs that indicates contact between the 2 cell types. On functional assays, DCs obtained from BM were more efficient than PB DCs in stimulating CD3- GLs, and surprisingly, a low but definite stimulatory effect was demonstrated also on CD3+ GLs. The putative contact between DCs and GLs in the BM and, more crucial, the proliferative response of discrete GL populations to DC stimulation suggest the presence of a specific antigen within BM DCs, providing evidence for a role of DCs in the pathogenesis of LDGL.
Similar articles
-
Analysis of TNF-receptor and ligand superfamily molecules in patients with lymphoproliferative disease of granular lymphocytes.Blood. 2000 Jul 15;96(2):647-54. Blood. 2000. PMID: 10887130
-
IL-12 is involved in the activation of CD3+ granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes.Br J Haematol. 1996 Feb;92(2):308-14. doi: 10.1046/j.1365-2141.1996.d01-1495.x. Br J Haematol. 1996. PMID: 8602990
-
Different mechanisms of activation of proliferating CD3+ cells in patients with lymphoproliferative disease of granular lymphocytes.Leukemia. 1991 Nov;5(11):942-50. Leukemia. 1991. PMID: 1835747
-
Natural killer receptors in patients with lymphoproliferative diseases of granular lymphocytes.Semin Hematol. 2003 Jul;40(3):201-12. doi: 10.1016/s0037-1963(03)00134-3. Semin Hematol. 2003. PMID: 12876669 Review.
-
Large granular lymphocytosis.Haematologica. 1998 Oct;83(10):936-42. Haematologica. 1998. PMID: 9830801 Review.
Cited by
-
CCL22 mutations drive natural killer cell lymphoproliferative disease by deregulating microenvironmental crosstalk.Nat Genet. 2022 May;54(5):637-648. doi: 10.1038/s41588-022-01059-2. Epub 2022 May 5. Nat Genet. 2022. PMID: 35513723 Free PMC article.
-
Intersection Between Large Granular Lymphocyte Leukemia and Rheumatoid Arthritis.Front Oncol. 2022 May 13;12:869205. doi: 10.3389/fonc.2022.869205. eCollection 2022. Front Oncol. 2022. PMID: 35646651 Free PMC article. Review.
-
Activating KIRs in Chronic Lymphoproliferative Disorder of NK Cells: Protection from Viruses and Disease Induction?Front Immunol. 2014 Feb 26;5:72. doi: 10.3389/fimmu.2014.00072. eCollection 2014. Front Immunol. 2014. PMID: 24616720 Free PMC article. Review.
-
Pro-inflammatory cells sustain leukemic clonal expansion in T-cell large granular lymphocyte leukemia.Haematologica. 2024 Jan 1;109(1):163-174. doi: 10.3324/haematol.2022.282306. Haematologica. 2024. PMID: 37439335 Free PMC article.
-
Pathogenesis and Treatment of T-Large Granular Lymphocytic Leukemia (T-LGLL) in the Setting of Rheumatic Disease.Front Oncol. 2022 Jun 7;12:854499. doi: 10.3389/fonc.2022.854499. eCollection 2022. Front Oncol. 2022. PMID: 35747794 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous